Epidemiologic Trends, Occurrence of Extended-Spectrum β-Lactamase Production, and Performance of Ertapenem and Comparators in Patients with Intra-Abdominal Infections: Analysis of Global Trend Data from 2002–2007 from the SMART Study

10.1089/sur.2006.7.537

10.1093/jac/dkl199

10.1089/mdr.2000.6.213

10.1093/jac/dki117

Clinical Laboratory Standards Institute, 2008, Performance Standards for Antimicrobial Susceptibility Testing: Thirteenth Information Supplement M100-S18

10.1128/JCM.01782-06

10.1128/JCM.01284-07

10.1089/sur.2008.0020

10.1016/j.diagmicrobio.2005.10.001

10.1016/j.diagmicrobio.2005.04.004

10.1016/j.diagmicrobio.2006.08.016

10.1089/sur.2005.6.439

10.12968/bjon.2007.16.11.23668

10.1111/j.1469-0691.2007.01848.x

10.1111/j.1469-0691.2008.02005.x

10.1111/j.1469-0691.2007.01862.x

10.1016/S1473-3099(08)70041-0

10.1086/502082

10.1086/501789

10.1067/mic.2003.70

10.1093/clinids/24.2.211

10.2307/30142426

10.1016/j.ajic.2003.09.002

Lipsitch M, 1997, Antimicrob Agents Chemother, 41, 363, 10.1128/AAC.41.2.363

10.2307/30142385

10.1128/AAC.49.7.2879-2886.2005